JCI Johnson Controls International PLC

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.        )

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

JOHNSON CONTROLS INTERNATIONAL PUBLIC LIMITED COMPANY

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

Your Vote Counts! JOHNSON CONTROLS INTERNATIONAL PLC 2024 Annual General Meeting Vote by March 13, 2024 11:59 PM ET JOHNSON CONTROLS INTERNATIONAL PLC ONE ALBERT QUAY CORK, IRELAND V27889-P01670-Z86571 ou invested in JOHNSON CONTROLS INTERNATIONAL PLC and it’s time to vote! You have the right to vote on proposals being presented at the Annual General Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on March 13, 2024. Get informed before you vote View the Combined Notice and Proxy Statement, Annual Report, Irish Statutory Accounts and Non-Financial Disclosure Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to February 15, 2024. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote in Person at the Meeting* March 13, 2024 3:00 PM, Local Time The Merrion Hotel 24 Upper Merrion Street Dublin 2, Ireland *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. We are monitoring public health developments and other circumstances, as well as guidance issued by relevant health organizations. Should we determine that alternative arrangements may be advisable or required, such as changing the date, time, location or format of the meeting, we will announce our decision by press release and post additional information on our Investor Relations section of our website. Furthermore, to promote the health and safety of attendees, we may impose additional procedures or limitations on meeting attendance based on applicable governmental requirements or recommendations or facility requirements. Voting Items Board Recommends Ordinary Business 1. By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company’s Annual General Meeting of Shareholders in 2025: Nominees: Timothy Archer For Jean Blackwell For Pierre Cohade For W. Roy Dunbar For Gretchen R. Haggerty For Ayesha Khanna For Seetarama (Swamy) Kotagiri For Simone Menne For George R. Oliver For Jurgen Tinggren For Mark Vergnano For John D. Young For 2.a To ratify the appointment of PricewaterhouseCoopers LLP as the independent auditors of the Company. For 2.b To authorize the Audit Committee of the Board of Directors to set the auditors’ remuneration. For Special Business To authorize the Company and/or any subsidiary of the Company to make market purchases of Company shares. For To determine the price range at which the Company can re-allot shares that it holds at treasury shares (Special Resolution). For To approve, in a non-binding advisory vote, the compensation of the named executive officers. For To approve the Directors’ authority to allot shares up to approximately 20% of issued share capital. For To approve the waiver of statutory preemption rights with respect to up to 20% of the issued share capital (Special Resolution). For Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V27890-P01670-Z86571